comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 16:34:23 - browse：3

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

knowledge

WSS

Why do women spend more than men on medical expenses?

Mindstrong's demise and the future of mental health care

Senator probes 340B programs at Cleveland Clinic, Bon Secours

How the Dana

Paxlovid should be available without a positive Covid test

FDA advisers vote against ALS treatment from BrainStorm

hotspot

comprehensive

entertainment

23andMe had bad news about my health. I wish a person had delivered it

The pink breast cancer awareness ribbon needs a redesign

Apple is now the first public company to be valued at $3 trillion

Medicaid, Medicare dual

The high cost of giving birth even with insurance

Readout Newsletter: XBI biotech index, Akero Therapeutics

Peter Hotez and the public health issue of online harassment

The FDA weighs the risks of candy

What does generative AI mean for health care? We asked experts

Diversifying clinical trials isn't enough to close racial gaps: study

explore

Intercept Pharmaceuticals sells itself for less than $1 billion

The pink breast cancer awareness ribbon needs a redesign

WHO recommends dropping component of many flu vaccines

Did you have Obamacare on your GOP debate bingo card?

Emergency medicine has repudiated 'excited delirium.' Now what?

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

focus

knowledge

focus

hotspot